Humpath.com - Human pathology - Photos - pictures - videos

SPINT2

HGNC:11247 19q13.1 Entrez:10653 MIM.605124

SPINT2 gene encodes a transmembrane protein with two extracellular Kunitz domains that inhibits a variety of serine proteases. The protein inhibits HGF activator which prevents the formation of active hepatocyte growth factor.

This gene is a putative tumor suppressor, and mutations in this gene result in congenital sodium diarrhea. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq] HAI-1 and HAI-2 may possibly be therapeutic target for treatment approaches in ovarian cancer.

Pathology

- syndromic congenital sodium diarrhea

  • Syndromic congenital sodium diarrhea is a distinct diseas entity cause by SPINT2 loss-of-function mutations.

- cancer

  • HAI-2 is a candidate tumour suppressor gene that is frequently hypermethylated and underexpressed in human HCCs, and the KD-1 domain of HAI-2 is the key region responsible for its anti-invasive function.
  • SPINT2 could be a putative tumor suppressor gene in medulloblastoma and further implicate dysregulation of the HGF/MET signaling pathway in the pathogenesis of medulloblastoma.
  • Epigenetic inactivation of HAI-2/SPINT2 causes loss of RCC tumor suppressor activity and implicates abnormalities of the MET pathway in clear cell and papillary sporadic RCC.
  • Frequent hypermethylation of SPINT2 gene in human hepatocellular carcinoma.

GeneRIF (February 2010)

- HAI-1 and HAI-2 may possibly be therapeutic target for treatment approaches in ovarian cancer

- Low HAI-2 expression in cervical cancer may be associated with a poor prognosis.

- Unlike HAI-1 and matriptase, HAI-2 expression is detected in non-epithelial cells of brain and lymph nodes, suggesting that HAI-2 may also be involved in inhibition of serine proteases other than matriptase

- HAI2 hypermethylation is associated with hepatocellular carcinoma

- Hepatocyte growth factor activator inhibitor 2 is regulated by hypoxia in breast cancer

- Overexpression of bikunin is associated with suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line

- cDNA microarray analysis of gene expression regulated by bikunin in an ovarian cell line, including the pattern of gene expression leading to a block in cell invasion.

- Urinary levels provide insight into proteinase/proteinase inhibitor imbalance in patients with inflammatory diseases.

- There is a distinct regulation of hepatocyte growth factor activator inhibitor type 2 gene expression in testis and that HAI-2 may play a role in the process of spermatogenesis

- Low level of HAI-2 is associated with breast cancer

- Bikunin downregulates constitutive & PMA-stimulated uPAR mRNA & protein Through suppression of upstream ERK cascade targets, whether cells were treated with exogenous bikunin or transfected with bikunin gene.

- Bikunin was colocalized with tryptase in dermal mast cells, and a small quantity of bikunin was also deposited in the intercellular spaces in FE and ADL.

- The use of high hydrostatic pressure (1000-3000 bar) for the refolding of bikunin aggregates was investigated.

- There are no significant differences in serum HAI-2 levels among prostate cancer subgroups according to clinical stage.

- suppresses lipopolysaccharide-induced lethality through down-regulation of tumor necrosis factor- alpha and interleukin-1 beta in macrophages.

- bik-R can physically interact with the CD44v isoforms containing epitope v9 and function as a repressor to down-regulate PMA-stimulated uPA expression, at least in part, by preventing clustering of CD44v isoforms containing epitope v9.

- Study demonstrates that the expression of HAI-2/PB is under methylation control to a variable extent in glioma cell lines, in comparison to the other tested neoplasm cell lines (brain, breast, prostate, liver).

- The active form of HGFA is specifically complexed with the membrane-form HAI-1 (serine peptidase inhibitor, Kunitz type 1), but not with HAI-2/PB (serine peptidase inhibitor, Kunitz type 2), on the surface of epithelial cells expressing both inhibitors.

See also

- SPINTs